MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding MAIA Biotechnology, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 14 | 22 | +8 |
| Shares | 318.3K | 803.3K | +485.0K (+152.4%) |
| Value | $699.6K | $957.8K | +$258.1K (+36.9%) |
New holders (9)
Institutions that held MAIA Biotechnology, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 130,510 | $152.7K | 1.35% |
| Renaissance Technologies LLC | 111,200 | $130.0K | 0.00% |
| Citadel Advisors LLC | 57,473 | $67.2K | 0.00% |
| XTX Topco Ltd | 23,965 | $28.0K | 0.01% |
| State Street Corp | 21,300 | $24.9K | 0.00% |
| Northern Trust Corp | 20,273 | $23.7K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 14,800 | $17.3K | 0.00% |
| Brookstone Capital Management | 12,658 | $14.8K | 0.00% |
| Bank of America Corp | 8 | $9 | 0.00% |
Sold out (1)
Institutions that held MAIA Biotechnology, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| FNY Investment Advisers, LLC | 17,550 | $38.0K |